| 1 |
35241487 | Experimental and Modeling Evidence Supporting the Trans-Inhibition Mechanism for Preincubation Time-Dependent, Long-Lasting Inhibition of Organic Anion Transporting Polypeptide 1B1 by Cyclosporine A. | 2022 May |
10 |
| 2 |
31901416 | Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters. | 2020 Feb |
1 |
| 3 |
30982223 | Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers. | 2019 Jul |
5 |
| 4 |
31703927 | Short-lasting inhibition of hepatic uptake transporter OATP1B1 by tyrosine kinase inhibitor pazopanib. | 2019 Dec |
1 |
| 5 |
29255993 | Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining. | 2018 Apr |
1 |
| 6 |
29712725 | Quantitative Analysis of Complex Drug-Drug Interactions between Cerivastatin and Metabolism/Transport Inhibitors Using Physiologically Based Pharmacokinetic Modeling. | 2018 Jul |
3 |
| 7 |
26961540 | Identification of Transporters Involved in Beraprost Sodium Transport In Vitro. | 2017 Feb |
1 |
| 8 |
27858342 | Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs). | 2017 Aug |
3 |
| 9 |
28479356 | Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data. | 2017 Sep |
2 |
| 10 |
28535976 | Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans. | 2017 Sep |
1 |
| 11 |
26353895 | Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir. | 2016 Feb |
1 |
| 12 |
27447836 | Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1. | 2016 Nov |
2 |
| 13 |
27603548 | Pre-incubation with cyclosporine A potentiates its inhibitory effects on pitavastatin uptake mediated by recombinantly expressed cynomolgus monkey hepatic organic anion transporting polypeptide. | 2016 Nov |
1 |
| 14 |
25414411 | Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions. | 2015 Feb |
2 |
| 15 |
25522788 | Physiology-based pharmacokinetics of caspofungin for adults and paediatrics. | 2015 Jun |
2 |
| 16 |
23886114 | In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia. | 2014 Mar |
1 |
| 17 |
24623479 | Reduced physiologically-based pharmacokinetic model of repaglinide: impact of OATP1B1 and CYP2C8 genotype and source of in vitro data on the prediction of drug-drug interaction risk. | 2014 Sep |
1 |
| 18 |
23440887 | Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake. | 2013 Sep |
2 |
| 19 |
22240838 | Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake. | 2012 |
8 |
| 20 |
21245207 | Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. | 2011 Mar |
1 |
| 21 |
21297316 | Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions. | 2011 Jun |
1 |
| 22 |
21430235 | Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. | 2011 Jun |
1 |
| 23 |
20519340 | Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin. | 2010 Sep |
1 |
| 24 |
20540932 | Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3. | 2010 Oct 1 |
1 |
| 25 |
17901929 | Multiple inhibition mechanisms and prediction of drug-drug interactions: status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions. | 2008 May |
1 |
| 26 |
18192894 | Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms. | 2008 Feb |
1 |
| 27 |
17496208 | Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. | 2007 Aug |
1 |
| 28 |
17178259 | Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. | 2006 Dec |
4 |
| 29 |
16198658 | Cyclosporine markedly raises the plasma concentrations of repaglinide. | 2005 Oct |
2 |
| 30 |
16316932 | Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport. | 2005 Jul |
1 |
| 31 |
16541750 | [Incremental effect and mechanism of cyclosporine on blood concentration of statins and statin package insert information in Japan]. | 2005 |
1 |
| 32 |
15289793 | Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. | 2004 Aug |
2 |
| 33 |
12538813 | Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. | 2003 Feb |
3 |
| 34 |
14530907 | Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. | 2003 Nov |
2 |